IL6 and ovarian carcinoma: The final model included “high” IL-6R expression but not IL-6 expression is a significant independent predictor for reduced PFS in ovarian cancer patients (P = 0.017, HR; 2.388 (1.171–4.895), Table 2) along with clinical stage and surgeries.